We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-10.56%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.98B
AUM Growth
-$122M
Cap. Flow
+$122M
Cap. Flow %
6.17%
Top 10 Hldgs %
22.19%
Holding
209
New
50
Increased
69
Reduced
49
Closed
37

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$52.1M
2
WBD icon
Warner Bros
WBD
+$34M
3
VTRS icon
Viatris
VTRS
+$33.3M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$28.3M
5
AKAM icon
Akamai
AKAM
+$27.8M

Top Sells

Rank Stock Value
1
TAP icon
Molson Coors Class B
TAP
+$37.4M
2
ES icon
Eversource Energy
ES
+$34.8M
3
T icon
AT&T
T
+$30M
4
SSNC icon
SS&C Technologies
SSNC
+$28M
5
PGNY icon
Progyny
PGNY
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 22.24%
2 Consumer Discretionary 18.14%
3 Healthcare 12.54%
4 Industrials 8.78%
5 Communication Services 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
201
Molson Coors Class B
TAP
$7.93B
-652,121
Closed -$37.4M
TXG icon
202
10x Genomics
TXG
$7.44B
-189,221
Closed -$2.72M
UGI icon
203
UGI
UGI
$7.29B
-614,910
Closed -$17.4M
UNIT
204
Uniti Group
UNIT
$2.28B
-578,903
Closed -$3.18M
W icon
205
Wayfair
W
$14.1B
-187,098
Closed -$8.29M
WRBY icon
206
Warby Parker
WRBY
$3.26B
-164,946
Closed -$3.99M
TBRG
207
DELISTED
TruBridge
TBRG
-72,483
Closed -$1.43M
SOLV icon
208
Solventum
SOLV
$14.5B
-320,609
Closed -$21.2M
VRN
209
DELISTED
Veren
VRN
-1,993,031
Closed -$10.2M

Similar funds

Invenomic Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Invenomic Capital Management held 209 positions worth $1.98B, down 5.8% from $2.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Invenomic Capital Management deployed $122M of net new capital in Q1 2025, opening 50 new positions and adding to 69 existing holdings. Its largest new stake was Warner Bros: 3,254,123 shares worth $34.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Eversource Energy, an estimated $34.8M trimmed.

  • Invenomic Capital Management's largest Q1 2025 buy was Warner Bros: 3,254,123 shares worth $34.9M.
  • Invenomic Capital Management added most to Teleflex in Q1 2025, an estimated $52.1M increase.
  • Invenomic Capital Management's biggest Q1 2025 reduction was Eversource Energy, cutting an estimated $34.8M.
  • Invenomic Capital Management fully exited Molson Coors Class B in Q1 2025, selling an estimated $37.4M.
  • Invenomic Capital Management's ten largest holdings make up 22% of its $1.98B portfolio in Q1 2025.
  • Invenomic Capital Management opened 50 new positions and closed 37 in Q1 2025.
  • Invenomic Capital Management's portfolio value fell 5.8% quarter-over-quarter to $1.98B.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.